Please assess the completion status of the following clinical trial:

Trial Title: Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of nonpsychotic major depressive disorder at least 4 weeks prior to study entry~* Clinical Global Impression severity score of 4 or greater~* Children's Depression Rating Scale score of 40 or greater~* Currently attending school~* Willing and able to use acceptable methods of contraception, if applicable~* In good general health~* Parent or guardian willing to provide informed consent, if applicable~Exclusion Criteria:~* History of psychotic disorders~* Alcohol or substance abuse or dependence within 6 months prior to study entry~* History of anorexia nervosa or bulimia~* Chronic medical illness requiring regular medication~* Current use of medication with psychotropic effects~* First-degree relatives (e.g., mother, father, sister, brother) with bipolar I disorder~* At risk for suicide~* Failure of a previous adequate treatment with fluoxetine (defined as at least 40 mg/day for 4 weeks)~* IQ less than 80~* Pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Continuation phase cognitive behavioral therapy and drug therapy for 6 more months following acute treatment response
- 2 (Type: ACTIVE_COMPARATOR): Continuation phase drug therapy only for 6 more months following acute treatment response

Based on this trial design, predict the completion outcome and termination type (if applicable).